The Latin America, Middle East and Africa Veterinary Orthopedic Implants Market would witness market growth of 7.5% CAGR during the forecast period (2022-2028).
The rising incidence of orthopaedic problems, such as injuries and arthritis, in animals is the primary factor fueling the expansion of the veterinary orthopaedic implants market. Consequently, this emphasises the need for veterinary orthopaedic implants in the field of orthopaedic medicine. There has also been a rise in the number of reported instances of canine cruciate ligament rupture.
The availability of better animal healthcare infrastructure, the rise in unmet animal healthcare demands, and the surge in demand for veterinary orthopaedics implants are all factors that are likely to fuel the growth of the veterinary orthopaedic implants market in unexplored, emerging regions. In addition, the development of cutting-edge surgical methods to treat the illness is seen as an opportunity for market growth throughout the forecast period. It's not just in the developed world where demand is rising for veterinary orthopaedic implants.
Brazil is a potential country in the regional pet food industry due to its high levels of pet ownership, increasing concern for pet health, and increased expenditure on natural, high-quality pet care. Small families, childless couples, and single people in Brazil's densely populated cities often keep fish and birds in addition to dogs and cats as pets because the country has the most varied pet population in the world. Also, many major companies are moving into the region to take advantage of the booming economy there. It is anticipated that these companies would introduce new, ground-breaking items at competitive prices to meet the market's unfulfilled needs. As a result of all this, the market is predicted to expand in the LAMEA region.
The Brazil market dominated the LAMEA Veterinary Orthopedic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,365.6 Thousands by 2028. The Argentina market is experiencing a CAGR of 8.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7.2% during (2022 - 2028).
Based on End User, the market is segmented into Hospital, Clinics, and Others. Based on Product Type, the market is segmented into Plates, Screws, and Others. Based on Application, the market is segmented into Cruciate Ligament Rupture, Bone Fractures, Hip Dysplasia, Elbow Dysplasia, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vimian Group AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Johnson & Johnson, OrthoMed, Inc., Arthrex, Inc., Auxein Medical Pvt. Ltd., Ortho Max Mfg. Co. Pvt. Ltd., BLUESAO Co., Ltd., and Narang Medical Limited.
The rising incidence of orthopaedic problems, such as injuries and arthritis, in animals is the primary factor fueling the expansion of the veterinary orthopaedic implants market. Consequently, this emphasises the need for veterinary orthopaedic implants in the field of orthopaedic medicine. There has also been a rise in the number of reported instances of canine cruciate ligament rupture.
The availability of better animal healthcare infrastructure, the rise in unmet animal healthcare demands, and the surge in demand for veterinary orthopaedics implants are all factors that are likely to fuel the growth of the veterinary orthopaedic implants market in unexplored, emerging regions. In addition, the development of cutting-edge surgical methods to treat the illness is seen as an opportunity for market growth throughout the forecast period. It's not just in the developed world where demand is rising for veterinary orthopaedic implants.
Brazil is a potential country in the regional pet food industry due to its high levels of pet ownership, increasing concern for pet health, and increased expenditure on natural, high-quality pet care. Small families, childless couples, and single people in Brazil's densely populated cities often keep fish and birds in addition to dogs and cats as pets because the country has the most varied pet population in the world. Also, many major companies are moving into the region to take advantage of the booming economy there. It is anticipated that these companies would introduce new, ground-breaking items at competitive prices to meet the market's unfulfilled needs. As a result of all this, the market is predicted to expand in the LAMEA region.
The Brazil market dominated the LAMEA Veterinary Orthopedic Implants Market by Country in 2021, and would continue to be a dominant market till 2028; thereby, achieving a market value of $2,365.6 Thousands by 2028. The Argentina market is experiencing a CAGR of 8.1% during (2022 - 2028). Additionally, The UAE market would display a CAGR of 7.2% during (2022 - 2028).
Based on End User, the market is segmented into Hospital, Clinics, and Others. Based on Product Type, the market is segmented into Plates, Screws, and Others. Based on Application, the market is segmented into Cruciate Ligament Rupture, Bone Fractures, Hip Dysplasia, Elbow Dysplasia, and Others. Based on countries, the market is segmented into Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Vimian Group AB, Integra LifeSciences Holdings Corporation, B. Braun Melsungen AG, Johnson & Johnson, OrthoMed, Inc., Arthrex, Inc., Auxein Medical Pvt. Ltd., Ortho Max Mfg. Co. Pvt. Ltd., BLUESAO Co., Ltd., and Narang Medical Limited.
Scope of the Study
Market Segments Covered in the Report:
By End User
- Hospital
- Clinics
- Others
By Product Type
- Plates
- Screws
- Others
By Application
- Cruciate Ligament Rupture
- Bone Fractures
- Hip Dysplasia
- Elbow Dysplasia
- Others
By Country
- Brazil
- Argentina
- UAE
- Saudi Arabia
- South Africa
- Nigeria
- Rest of LAMEA
Key Market Players
List of Companies Profiled in the Report:
- Vimian Group AB
- Integra LifeSciences Holdings Corporation
- B.Braun Melsungen AG
- Johnson & Johnson
- OrthoMed, Inc
- Arthrex, Inc
- Auxein Medical Pvt. Ltd
- Ortho Max Mfg. Co. Pvt. Ltd
- BLUESAO Co., Ltd
- Narang Medical Limited
Unique Offerings
- Exhaustive coverage
- The highest number of Market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Chapter 1. Market Scope & Methodology1.1 Market Definition
1.2 Objectives
1.3 Market Scope
1.4 Segmentation
1.4.1 LAMEA Veterinary Orthopedic Implants Market, by End User
1.4.2 LAMEA Veterinary Orthopedic Implants Market, by Product Type
1.4.3 LAMEA Veterinary Orthopedic Implants Market, by Application
1.4.4 LAMEA Veterinary Orthopedic Implants Market, by Country
1.5 Methodology for the research
Chapter 2. Market Overview
2.1 Introduction
2.1.1 Overview
2.1.1.1 Market Composition & Scenario
2.2 Key Factors Impacting the Market
2.2.1 Market Drivers
2.2.2 Market Restraints
Chapter 3. LAMEA Veterinary Orthopedic Implants Market by End User
3.1 LAMEA Hospital Market by Country
3.2 LAMEA Clinics Market by Country
3.3 LAMEA Others Market by Country
Chapter 4. LAMEA Veterinary Orthopedic Implants Market by Product Type
4.1 LAMEA Plates Market by Country
4.2 LAMEA Screws Market by Country
4.3 LAMEA Others Market by Country
Chapter 5. LAMEA Veterinary Orthopedic Implants Market by Application
5.1 LAMEA Cruciate Ligament Rupture Market by Country
5.2 LAMEA Bone Fractures Market by Country
5.3 LAMEA Hip Dysplasia Market by Country
5.4 LAMEA Elbow Dysplasia Market by Country
5.5 LAMEA Others Market by Country
Chapter 6. LAMEA Veterinary Orthopedic Implants Market by Country
6.1 Brazil Veterinary Orthopedic Implants Market
6.1.1 Brazil Veterinary Orthopedic Implants Market by End User
6.1.2 Brazil Veterinary Orthopedic Implants Market by Product Type
6.1.3 Brazil Veterinary Orthopedic Implants Market by Application
6.2 Argentina Veterinary Orthopedic Implants Market
6.2.1 Argentina Veterinary Orthopedic Implants Market by End User
6.2.2 Argentina Veterinary Orthopedic Implants Market by Product Type
6.2.3 Argentina Veterinary Orthopedic Implants Market by Application
6.3 UAE Veterinary Orthopedic Implants Market
6.3.1 UAE Veterinary Orthopedic Implants Market by End User
6.3.2 UAE Veterinary Orthopedic Implants Market by Product Type
6.3.3 UAE Veterinary Orthopedic Implants Market by Application
6.4 Saudi Arabia Veterinary Orthopedic Implants Market
6.4.1 Saudi Arabia Veterinary Orthopedic Implants Market by End User
6.4.2 Saudi Arabia Veterinary Orthopedic Implants Market by Product Type
6.4.3 Saudi Arabia Veterinary Orthopedic Implants Market by Application
6.5 South Africa Veterinary Orthopedic Implants Market
6.5.1 South Africa Veterinary Orthopedic Implants Market by End User
6.5.2 South Africa Veterinary Orthopedic Implants Market by Product Type
6.5.3 South Africa Veterinary Orthopedic Implants Market by Application
6.6 Nigeria Veterinary Orthopedic Implants Market
6.6.1 Nigeria Veterinary Orthopedic Implants Market by End User
6.6.2 Nigeria Veterinary Orthopedic Implants Market by Product Type
6.6.3 Nigeria Veterinary Orthopedic Implants Market by Application
6.7 Rest of LAMEA Veterinary Orthopedic Implants Market
6.7.1 Rest of LAMEA Veterinary Orthopedic Implants Market by End User
6.7.2 Rest of LAMEA Veterinary Orthopedic Implants Market by Product Type
6.7.3 Rest of LAMEA Veterinary Orthopedic Implants Market by Application
Chapter 7. Company Profiles
7.1 Vimian Group AB
7.1.1 Company Overview
7.1.2 Financial Analysis
7.1.3 Segmental and Regional Analysis
7.1.4 Recent strategies and developments:
7.1.4.1 Acquisition and Mergers:
7.1.4.2 Geographical Expansions:
7.2 Integra LifeSciences Holdings Corporation
7.2.1 Company Overview
7.2.2 Financial Analysis
7.2.3 Segmental and Regional Analysis
7.2.4 Research & Development Expense
7.2.5 Recent strategies and developments:
7.2.5.1 Acquisition and Mergers:
7.3 B. Braun Melsungen AG
7.3.1 Company Overview
7.3.2 Financial Analysis
7.3.3 Segmental and Regional Analysis
7.3.4 Research & Development Expenses
7.4 Johnson & Johnson
7.4.1 Company Overview
7.4.2 Financial Analysis
7.4.3 Segmental &Regional Analysis
7.4.4 Research & Development Expenses
7.5 OrthoMed, Inc.
7.5.1 Company Overview
7.6 Arthrex, Inc.
7.6.1 Company Overview
7.7 Auxein Medical Pvt. Ltd.
7.7.1 Company Overview
7.8 Ortho Max Mfg. Co. Pvt. Ltd.
7.8.1 Company Overview
7.9 BLUESAO Co., Ltd.
7.9.1 Company Overview
7.10. Narang Medical Limited
7.10.1 Company Overview
Companies Mentioned
- Vimian Group AB
- Integra LifeSciences Holdings Corporation
- B. Braun Melsungen AG
- Johnson & Johnson
- OrthoMed, Inc.
- Arthrex, Inc.
- Auxein Medical Pvt. Ltd.
- Ortho Max Mfg. Co. Pvt. Ltd.
- BLUESAO Co., Ltd.
- Narang Medical Limited
Methodology
LOADING...
